Christopher Boerner; Chairman of the Board, Chief Executive Officer, Chief Operating Officer; Bristol-Myers Squibb Co David Elkins; Executive Vice President, Chief Financial Officer, Member of the ...

Operator Welcome to the Bristol Myers Squibb fourth quarter 2024 earnings conference call. [Operator instructions] Please note this event is being recorded. I would now like to turn the conference ...

The EIB has extended a €42.8 million loan to Ústí nad Labem for crucial infrastructure upgrades, including energy, transport, and social serv ...

At Enforce Tac 2025, the leading trade fair for internal and external security, a new and highly topical forum will make its ...

Bristol-Myers Squibb (NYSE:BMY) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings ...

The EIB is loaning €466 million to the Czech Republic to upgrade railway infrastructure as part of a larger European effort to improve rail ser ...

Net sales increased by 13.4 percent and amounted to SEK 5,025 million (4,433). Organic growth, including bolt-on acquisitions, was 6.6 percent. Operating profit ...